Data protection Impressum

Life sciences

Geneva has inaugurated its first AI health hub at Campus Biotech to advance AI-driven care, research and neurotechnology in Western Switzerland.

Geneva inaugurates its first AI health hub at Campus Biotech

8 December 2025

Inselspital Bern has performed its 300th CAR-T cell therapy treatment, underscoring Western Switzerland’s role as a leading center for advanced immuno-oncology.

Bern’s Inselspital marks a new era in personalized cancer treatment

8 December 2025

Researchers at CHUV have validated a new stem-cell–based method to study autoimmune diseases in organs such as the brain, offering new insights into conditions like autoimmune encephalitis and multiple sclerosis.

CHUV researchers develop new method to study autoimmune diseases

2 December 2025

Artiria Medical has received CE Mark certification for its SmartGUIDE 014 guidewire, enabling commercialization across Europe and expanding clinical adoption for stroke and aneurysm interventions.

Artiria Medical obtains CE Mark for its deflectable guidewire

2 December 2025

Takeda has opened a new CHF 200 million biotechnology facility in Neuchâtel to expand aseptic filling capacity for rare disease therapies.

Takeda inaugurates CHF 200 million biotechnology facility in Neuchâtel

1 December 2025

CHUV has opened a new ambulatory radiology facility in Lausanne to centralize imaging services and modernize its diagnostic infrastructure.

CHUV opens new ambulatory radiology facility to improve patient access and diagnostic capacity

25 November 2025

Distalmotion has raised USD 150 million in Series G financing to accelerate the U.S. expansion of its DEXTER surgical robot.

Distalmotion raises USD 150 million to scale its DEXTER surgical robot in the United States

19 November 2025

LEM Surgical has completed its first U.S. clinical procedures using the Dynamis Robotic Surgical System.

Bern’s LEM Surgical completes first U.S. clinical procedures with its Dynamis robotic system

19 November 2025

A Swiss-led research consortium is developing an AI-powered microfactory capable of producing patient-specific tumor models to revolutionize precision oncology.

ORION: A smart microfactory to accelerate personalized cancer treatments

10 November 2025

The Munich- and Lausanne-based biotech secures Europe’s largest-ever Series C financing to accelerate development of next-generation antibody-drug conjugates.

Tubulis raises EUR 308 million to advance ADC therapies and expand its clinical pipeline

29 October 2025

1 2 3 4 5 6 … 47